Pulmonary Hypertension
Pulmonary hypertension (PH) is a condition characterized by high blood pressure in the pulmonary arteries, which can lead to heart failure and other serious complications. Recent studies have suggested potential benefits of the ketogenic diet for patients with pulmonary hypertension. At National Jewish Health, our research programs aim to improve the understanding, diagnosis and treatment of pulmonary hypertension. Here is an overview of our pulmonary hypertension research programs:
- Pulmonary Hypertension Research Center: This center provides specialized care for patients with pulmonary hypertension, combining clinical expertise with cutting-edge research to advance treatment and improve patient outcomes.
- Pulmonary Hypertension Research: Researchers investigate various aspects of pulmonary hypertension, including its causes, progression and response to treatment. Investigators focus on the underlying mechanisms of the condition, such as endothelial dysfunction, vasoconstriction and remodeling of the pulmonary arteries. Research efforts are aimed at developing and optimizing therapies to improve disease management.
- Clinical Trials and Studies: Our physician-scientists conduct clinical trials to evaluate new and emerging treatments for pulmonary hypertension, working to identify more effective therapies and improve patient outcomes.
- Pulmonary Hypertension Research Advancements: Use of the ketogenic diet to improves pulmonary hypertension patient outcomes. Mechanism for sex differences in pulmonary hypertension patient outcomes.
-
Tyler J. Couch, MD
-
Andrew M. Freeman, MD, FACC, FACP
-
Marjorie Patricia George, MD
-
Kristen Glisinski, MD
-
Tim Lahm, MD, ATSF
-
Susan M. Majka, PhD
-
Karina Mora Massad, MD
-
Irina Petrache, MD
-
Soonho Yoon, MD, PhD